Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Molecular and Cellular Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1629656

This article is part of the Research TopicNational Cancer Research Month 2025: Advances in Detection, Treatment and Therapies in OncologyView all 6 articles

A study on the clinical value of prophylactic contralateral central lymph node dissection in patients with cT1-T2N1b unilateral papillary thyroid cancer

Provisionally accepted
Suqiong  LinSuqiong Lin1Rongliang  QiuRongliang Qiu2Yujuan  TangYujuan Tang3Xiaoquan  HongXiaoquan Hong1Qiangbin  DingQiangbin Ding1Ke  LiKe Li1Ende  LinEnde Lin1Penghao  KuangPenghao Kuang1Jinbo  FuJinbo Fu1*Guoyang  WuGuoyang Wu1*
  • 1Zhongshan Hospital, Xiamen University, Xiamen, China
  • 2Fujian Medical University, Fuzhou, China
  • 3Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei, China

The final, formatted version of the article will be published soon.

Lateral lymph node metastasis (cN1b) is a major factor affecting the prognosis and recurrence of papillary thyroid cancer (PTC). Currently, there is some controversy regarding whether to dissect the contralateral central lymph nodes in patients with cT1-T2N1b unilateral PTC. The purpose of this study was to investigate the risk factors for contralateral central lymph node metastasis (CCLNM) and to summarize the significance of prophylactic contralateral central lymph node dissection (CCLND), to provide reference information for clinical intervention.The data of 99 patients with cT1-T2N1b unilateral PTC from August 2021 to October 2024 were retrospectively analyzed. Multifactorial analysis was performed using logistic regression to analyze the risk factors for CCLNM in patients with cT1-T2N1b unilateral PTC. The analysis of the CCLNM rate and metastasis mode summarized the clinical significance of prophylactic CCLND.CCLNM occurred in 55 cases (55/99,55.6%), and the total number of lymph nodes cleared from the contralateral central lymph node was 6.1±4.9, of which the number of metastatic lymph nodes was 1.5±1.9; There was no statistically significant difference between the CCLNM and non-metastasis groups in terms of the rate of lymph node metastasis in the ipsilateral lateral cervical region (zones Ⅱ, Ⅲ, Ⅳ and Ⅴ ) and the ipsilateral central zone (P>0.05). There was no statistically significant difference between the metastatic group and the non-metastatic group in terms of the number of lymph nodes cleared in the ipsilateral lateral cervical region (zones Ⅱ, Ⅲ, Ⅳ and Ⅴ ) (P > 0.05). Compared with the non-metastatic group, the metastatic group had more positive lymph nodes and fewer negative lymph nodes in the ipsilateral central region, and the difference was statistically significant (P < 0.05).Logistic regression analysis showed that microcalcification and Hashimoto's thyroiditis in the metastasis group were independent factors for the occurrence of CCLNM, and the difference was statistically significant (P<0.05).The occurrence of CCLNM in cT1-T2N1b unilateral PTC is related to several factors. Lymph node dissection can help reduce the risk of recurrence and reoperation due to CCLNM; therefore CCLND cannot be ignored.

Keywords: Papillary thyroid carcinoma, Lateral lymph node metastasis, Contralateral central lymph node metastasis, Preventive central lymph node dissection, surgical treatment

Received: 16 May 2025; Accepted: 30 Jun 2025.

Copyright: © 2025 Lin, Qiu, Tang, Hong, Ding, Li, Lin, Kuang, Fu and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jinbo Fu, Zhongshan Hospital, Xiamen University, Xiamen, China
Guoyang Wu, Zhongshan Hospital, Xiamen University, Xiamen, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.